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Vaccination: still a challenge, always a hope
by Freddie Theodoulou, Science Editor
Which is the greater threat to humankind: 
animal disease or plant disease?
We asked this question in a quiz compiled 
by the Biochemical Society for Fascination 
of Plants Day 2017. The answer of course, is 
that both are potentially devastating. Whilst 
innumerable lives have been lost globally 
to infectious diseases such as smallpox, around a million people 
starved in 19th Century Ireland when potato blight decimated their 
staple crop. Hunger kills as efficiently as viruses and bacteria. Thanks 
to vaccination, the World Health Organisation declared smallpox 
eradicated in 1980, but as diseases are eliminated or controlled, new 
ones arise: now researchers and medics confront Ebola and multidrug 
resistant bacteria, while plant scientists and farmers scramble to avoid 
losing the world’s wheat crop to virulent forms of rust fungus. Whatever 
the pathogen, successful solutions to emerging diseases will depend not 
only on scientific inquiry, but also on how well the fruits of research are 
communicated and delivered to society. 
The battle with smallpox can be traced to antiquity: Egyptian 
mummies bear witness to the disease which eventually spread to India 
and Europe and possibly contributed to the downfall of the Roman 
Empire a thousand years later. Introduction to the Americas by the 
Conquistadors had similarly devastating consequences. But it was 
realized as early as 430 BC that survivors had immunity to smallpox 
and although evidence is sparse, the practice of variolation- inoculation 
of non-immune individuals with smallpox virus- appears to have arisen 
independently in several countries.
Much as the scientific community faces resistance from “anti-
vaxxers” today, variolation met with considerable opposition. Jenner 
owes a debt to a lesser-known smallpox hero, English aristocrat Lady 
Mary Wortley Montague, a passionate advocate who (unlike Tony 
Blair during the UK MMR triple vaccine controversy) persuaded 
Royal physicians to trial the practice by having her daughter publicly 
variolated in 1721. Across the Atlantic, the Rev. Cotton Mather’s 
attempts to prevent the Boston epidemic of the same year resulted in 
his house being bombed, but his ground-breaking statistical analysis 
of mortality rates influenced the widespread adoption of variolation. 
Jenner himself was immunized a quarter of a century later at the age 
of 8 and survived to spend a lifetime being both honoured and abused 
for his vaccination work. The 1800s saw extensive vaccination but 
despite unquestionable success stories, modern day objections still 
mirror those of 19th Century antivaccinationists. Some problems 
have scientific solutions- producing vaccines in plants, for example, 
may satisfy anti-vivisectionists. Much harder to address are moral 
and philosophical issues, particularly the tension between individual 
choice and common good. With a limited repertoire of anti-viral 
therapies and the inexorable march of evolution, the promise of 
vaccines and the case for advocacy remain as strong as ever.  ■
Further reading:  Riedel, S. (2005) Edward Jenner and the history of small-
pox and vaccination. BUMC Proceedings 18, 21-25.
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